Open vs. robot-assisted radical cystectomy with extracorporeal or intracorporeal urinary diversion for bladder cancer: A pairwise meta-analysis of outcomes and a network meta-analysis of complications by urinary diversion approach;
Riveros, C, Ranganathan, S, Nipper, C, Lim, K, Brooks, M, Dursun, F, Miles, BJ, Goh, A, Desai, M, Klaassen, Z, Kulkarni, GS, Wallis, CJD & Satkunasivam, R 2023, , Journal of the Canadian Urological Association, vol. 17, no. 3.

Inhibiting androgen receptor splice variants with cysteine-selective irreversible covalent inhibitors to treat prostate cancer;
Thiyagarajan, T, Ponnusamy, S, Huang, D, He, Y, Asemota, S, Young, K, Johnson, D, Bocharova, V, Zhou, W, Jain, A, Petricoin, E, Yin, Z, Pfeffer, L, Miller, D & Narayanan, R 2023, , Proceedings of the National Academy of Sciences of the United States of America, vol. 120, no. 1, 120 (1) e2211832120.

Computational approaches for multiscale modeling;
Butner, J, Dogra, P, Cristini, V, Deisboeck, TS & Wang, Z 2023, . in RA Bradshaw, PD Stahl & J Hart (eds), Encyclopedia of Cell Biology. 2 edn, Elsevier.

Memory Macrophages;
Kloc, M, Kubiak, JZ, Zdanowski, R & Ghobrial, RM 2023, , International journal of molecular sciences, vol. 24, no. 1, 38.

Outcomes in liver transplant recipients with nonalcoholic fatty liver disease-related HCC: results from the US multicenter HCC transplant consortium;
US Multicenter HCC Transplant Consortium 2023, , Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, vol. 29, no. 1, pp. 34-47.

Impact of Infections in Patients Receiving Pembrolizumab-Based Therapies for Non-Small Cell Lung Cancer;
Burns, EA, Gee, K, Kieser, RB, Xu, J, Zhang, Y, Crenshaw, A, Muhsen, IN, Mylavarapu, C, Esmail, A, Shah, S, Umoru, G, Sun, K, Guerrero, C, Gong, Z, Heyne, K, Singh, M, Zhang, J, Bernicker, EH & Abdelrahim, M 2023, , Cancers, vol. 15, no. 1, 81.

Implantable niche with local immunosuppression for islet allotransplantation achieves type 1 diabetes reversal in rats;
Paez-Mayorga, J, Campa-Carranza, JN, Capuani, S, Hernandez, N, Liu, H-C, Chua, CYX, Pons-Faudoa, FP, Malgir, G, Alvarez, B, Niles, JA, Argueta, LB, Shelton, KA, Kezar, S, Nehete, PN, Berman, DM, Willman, MA, Li, XC, Ricordi, C, Nichols, JE, Gaber, AO, Kenyon, NS & Grattoni, A 2022, , Nature Communications, vol. 13, no. 1, pp. 7951.

Emerging immunomodulatory strategies for cell therapeutics;
Chua, CYX, Jiang, AY, Eufrásio-da-Silva, T, Dolatshahi-Pirouz, A, Langer, R, Orive, G & Grattoni, A 2022, , Trends in Biotechnology.

Protocol for mathematical prediction of patient response and survival to immune checkpoint inhibitor immunotherapy;
Butner, JD, Farhat, M, Cristini, V, Chung, C & Wang, Z 2022, , STAR Protocols, vol. 3, no. 4, 101886.